KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Cash from Investing Activities: 2019-2025

Historic Cash from Investing Activities for Hims & Hers Health (HIMS) over the last 6 years, with Sep 2025 value amounting to -$887.4 million.

  • Hims & Hers Health's Cash from Investing Activities fell 8421.20% to -$887.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$958.5 million, marking a year-over-year decrease of 5184.01%. This contributed to the annual value of -$19.0 million for FY2024, which is 57.34% down from last year.
  • Hims & Hers Health's Cash from Investing Activities amounted to -$887.4 million in Q3 2025, which was down 4,108.07% from -$21.1 million recorded in Q2 2025.
  • Over the past 5 years, Hims & Hers Health's Cash from Investing Activities peaked at $22.7 million during Q2 2021, and registered a low of -$887.4 million during Q3 2025.
  • In the last 3 years, Hims & Hers Health's Cash from Investing Activities had a median value of -$10.4 million in 2024 and averaged -$88.4 million.
  • In the last 5 years, Hims & Hers Health's Cash from Investing Activities surged by 417.09% in 2024 and then plummeted by 8,421.20% in 2025.
  • Hims & Hers Health's Cash from Investing Activities (Quarterly) stood at $10.2 million in 2021, then plummeted by 41.39% to $6.0 million in 2022, then surged by 244.74% to $20.7 million in 2023, then tumbled by 183.14% to -$17.2 million in 2024, then slumped by 8,421.20% to -$887.4 million in 2025.
  • Its Cash from Investing Activities was -$887.4 million in Q3 2025, compared to -$21.1 million in Q2 2025 and -$32.8 million in Q1 2025.